InsiderClue
Stocks · Health care · Pharmaceutical Preparations

RedHill Biopharma Ltd.

RDHL Clue Score17
Israel CIK 0001553846
$0.54 -6.75% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.54 −88.65% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue0.1Operating income−30.5Net income−29.4EPS, diluted−0.24Fiscal year 2017Revenue4.0 +3,867.3%Operating income−52.0Net income−45.5EPS, diluted−0.26Fiscal year 2018Revenue8.4 +108.6%Operating income−39.3Net income−38.8EPS, diluted−0.17Fiscal year 2019Revenue6.3 −24.7%Operating income−43.2Net income−42.3EPS, diluted−0.14Fiscal year 2020Revenue64.4 +923.0%Operating income−63.7Net income−76.2EPS, diluted−0.21Fiscal year 2021Revenue85.8 +33.2%Operating income−81.1Net income−97.7EPS, diluted−0.21Fiscal year 2022Revenue61.8 −27.9%Operating income−42.8Net income−71.7EPS, diluted−0.12Fiscal year 2023Revenue6.5 −89.4%Operating income12.6Net income23.9EPS, diluted0.01Fiscal year 2024Revenue8.0 +23.2%Operating income−14.6Net income−8.3 −134.6%EPS, diluted0.00 −100.0%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Revenue 0.1 4.0 8.4 6.3 64.4 85.8 61.8 6.5 8.0
Growth +3,867.3% +108.6% −24.7% +923.0% +33.2% −27.9% −89.4% +23.2%
Operating income −30.5 −52.0 −39.3 −43.2 −63.7 −81.1 −42.8 12.6 −14.6
Net income −29.4 −45.5 −38.8 −42.3 −76.2 −97.7 −71.7 23.9 −8.3
Growth −134.6%
EPS, diluted −0.24 −0.26 −0.17 −0.14 −0.21 −0.21 −0.12 0.01 0.00
Growth −100.0%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin100.0%Operating margin−30,240.6%Net margin−29,079.2%Free cash flow margin−28,062.4%Fiscal year 2017Gross margin46.9%Operating margin−1,297.0%Net margin−1,136.6%Free cash flow margin−1,120.9%Fiscal year 2018Gross margin66.1%Operating margin−470.5%Net margin−464.4%Free cash flow margin−412.5%Fiscal year 2019Gross margin64.1%Operating margin−686.7%Net margin−672.5%Free cash flow margin−650.4%Fiscal year 2020Gross margin42.7%Operating margin−99.0%Net margin−118.4%Free cash flow margin−76.1%Fiscal year 2021Gross margin42.4%Operating margin−94.6%Net margin−114.0%Free cash flow margin−76.0%Fiscal year 2022Gross margin46.1%Operating margin−69.3%Net margin−116.0%Free cash flow margin−47.5%Fiscal year 2023Gross margin47.0%Operating margin193.4%Net margin366.2%Free cash flow margin−548.7%Fiscal year 2024Gross margin60.3%Operating margin−181.7%Net margin−102.8%Free cash flow margin−116.6%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Gross margin 100.0% 46.9% 66.1% 64.1% 42.7% 42.4% 46.1% 47.0% 60.3%
Operating margin −30,240.6% −1,297.0% −470.5% −686.7% −99.0% −94.6% −69.3% 193.4% −181.7%
Net margin −29,079.2% −1,136.6% −464.4% −672.5% −118.4% −114.0% −116.0% 366.2% −102.8%
Free cash flow margin −28,062.4% −1,120.9% −412.5% −650.4% −76.1% −76.0% −47.5% −548.7% −116.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−28.3Capital expenditure−0.1Free cash flow−28.3Fiscal year 2017Operating cash flow−44.8Capital expenditure−0.1Free cash flow−44.9Fiscal year 2018Operating cash flow−34.5Capital expenditure−0.0Free cash flow−34.5Fiscal year 2019Operating cash flow−40.7Capital expenditure−0.2Free cash flow−40.9Fiscal year 2020Operating cash flow−48.6Capital expenditure−0.4Free cash flow−49.0Fiscal year 2021Operating cash flow−65.0Capital expenditure−0.1Free cash flow−65.2Fiscal year 2022Operating cash flow−29.2Capital expenditure−0.2Free cash flow−29.4Fiscal year 2023Operating cash flow−35.8Capital expenditure−0.0Free cash flow−35.8Fiscal year 2024Operating cash flow−9.4Capital expenditure−0.0Free cash flow−9.4
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Operating cash flow −28.3 −44.8 −34.5 −40.7 −48.6 −65.0 −29.2 −35.8 −9.4
Capital expenditure −0.1 −0.1 −0.0 −0.2 −0.4 −0.1 −0.2 −0.0 −0.0
Free cash flow −28.3 −44.9 −34.5 −40.9 −49.0 −65.2 −29.4 −35.8 −9.4
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash53.8Shareholders’ equity62.7Fiscal year 2017Cash16.5Shareholders’ equity45.1Fiscal year 2018Cash29.0Shareholders’ equity51.2Fiscal year 2019Cash29.0Shareholders’ equity60.0Fiscal year 2020Cash29.3Total debt81.4Net cash (debt)−52.1Shareholders’ equity13.9Debt to equity5.87Fiscal year 2021Cash29.5Total debt83.6Net cash (debt)−54.1Shareholders’ equity8.9Debt to equity9.42Fiscal year 2022Cash20.0Shareholders’ equity−48.4Fiscal year 2023Cash5.6Shareholders’ equity2.1Fiscal year 2024Cash4.6Shareholders’ equity−4.7
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Cash 53.8 16.5 29.0 29.0 29.3 29.5 20.0 5.6 4.6
Total debt n/a n/a n/a n/a 81.4 83.6 n/a n/a n/a
Net cash (debt) n/a n/a n/a n/a −52.1 −54.1 n/a n/a n/a
Shareholders’ equity 62.7 45.1 51.2 60.0 13.9 8.9 −48.4 2.1 −4.7
Debt to equity n/a n/a n/a n/a 5.87 9.42 n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2024 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024
Assets
53.8 16.5 29.0 29.0 29.3 29.5 20.0 5.6 4.6
0.1 1.5 1.0 1.2 28.7 31.7 34.5 2.6 2.5
n/a 0.7 0.8 1.9 6.5 14.8 11.0 4.4 3.7
0.2 0.2 0.2 0.2 0.5 0.6 0.5 0.2 0.1
74.2 57.3 62.4 74.1 180.2 181.2 158.9 23.0 18.0
Growth −22.7% +8.8% +18.7% +143.2% +0.5% −12.3% −85.5% −21.7%
Liabilities
n/a n/a n/a n/a 81.4 83.6 n/a n/a n/a
calc n/a n/a n/a n/a 81.4 83.6 n/a n/a n/a
11.5 12.3 11.2 14.1 166.4 172.3 207.3 21.0 22.7
Equity
−89.6 −132.9 −169.1 −208.4 −280.3 −367.9 −433.9 −407.7 −414.8
62.7 45.1 51.2 60.0 13.9 8.9 −48.4 2.1 −4.7
Growth −28.1% +13.6% +17.2% −76.9% −36.0% −645.4% −326.3%
Per share and net cash
calc n/a n/a n/a n/a −52.1 −54.1 n/a n/a n/a
n/a 212.7 283.7 352.7 384.0 526.8 1,180 12,747 12,900
calc n/a 0.21 0.18 0.17 0.04 0.02 −0.04 0.00 −0.00

Lines marked calc are worked out here from filed figures; point at one for how.